File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1158/1538-7445.AM2011-4414
- WOS: WOS:000209701401386
- Find via
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Conference Paper: Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion
Title | Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion |
---|---|
Authors | |
Keywords | Medical sciences Oncology |
Issue Date | 2011 |
Publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ |
Citation | The 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8 suppl. 1, abstract no. 4414 How to Cite? |
Abstract | BACKGROUND: Hepatocellular carcinoma (HCC) is among the most lethal of human malignancies. It is difficult to detect early, has a high recurrence rate and is refractory to chemotherapies. Amplification of 1q21 is one of the most frequent genetic alterations in HCC. CHD1L is a newly identified oncogene responsible for 1q21 amplicon. This study aims to investigate the role of CHD1L in predicting prognosis and chemotherapy response of HCC patients ... |
Description | Poster Presentations - New Target Models and Tumor Classification: abstract no. 4414 This journal suppl. entitled: Proceedings: AACR 102nd Annual Meeting 2011 |
Persistent Identifier | http://hdl.handle.net/10722/137868 |
ISSN | 2023 Impact Factor: 12.5 2023 SCImago Journal Rankings: 3.468 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, L | en_US |
dc.contributor.author | Chan, HM | en_US |
dc.contributor.author | Guan, XY | en_US |
dc.date.accessioned | 2011-08-26T14:35:43Z | - |
dc.date.available | 2011-08-26T14:35:43Z | - |
dc.date.issued | 2011 | en_US |
dc.identifier.citation | The 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8 suppl. 1, abstract no. 4414 | en_US |
dc.identifier.issn | 0008-5472 | - |
dc.identifier.uri | http://hdl.handle.net/10722/137868 | - |
dc.description | Poster Presentations - New Target Models and Tumor Classification: abstract no. 4414 | - |
dc.description | This journal suppl. entitled: Proceedings: AACR 102nd Annual Meeting 2011 | - |
dc.description.abstract | BACKGROUND: Hepatocellular carcinoma (HCC) is among the most lethal of human malignancies. It is difficult to detect early, has a high recurrence rate and is refractory to chemotherapies. Amplification of 1q21 is one of the most frequent genetic alterations in HCC. CHD1L is a newly identified oncogene responsible for 1q21 amplicon. This study aims to investigate the role of CHD1L in predicting prognosis and chemotherapy response of HCC patients ... | - |
dc.language | eng | en_US |
dc.publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ | - |
dc.relation.ispartof | Cancer Research | en_US |
dc.subject | Medical sciences | - |
dc.subject | Oncology | - |
dc.title | Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Chen, L: pollyllc@hku.hk | en_US |
dc.identifier.email | Chan, HM: chantim@hkucc.hku.hk | en_US |
dc.identifier.email | Guan, XY: xyguan@hkucc.hku.hk | en_US |
dc.identifier.authority | Guan, XY=rp00454 | en_US |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1158/1538-7445.AM2011-4414 | - |
dc.identifier.hkuros | 190900 | en_US |
dc.identifier.volume | 71 | - |
dc.identifier.issue | 8 suppl. 1 | - |
dc.identifier.isi | WOS:000209701401386 | - |
dc.publisher.place | United States | - |
dc.description.other | The 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8, suppl. 1, abstract no. 4414 | - |
dc.identifier.issnl | 0008-5472 | - |